President, Cell Therapy Org. · BRISTOL MYERS SQUIBB CO · Common Stock, $0.10 par value
Side
F
Value
$55K
Shares
912
Price
$60.13
Executed
Mar 10, 2026
Disclosed
Mar 12, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 10 executedMar 12, 2026 disclosed
BMY · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+8 / 25
$55K reported value · 12.5% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hoch Lynelle filed this Form 4 reporting a tax withholding of BMY on Mar 10, 2026. It became public on Mar 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
President, Cell Therapy Org.
Hoch Lynellecik:0002005382
Issuer
BRISTOL MYERS SQUIBB COcik:0000014272
Revision history · 0
No field has changed since this record was first ingested.
